Nicole Labrosse Net Worth & Insider Trades

Nicole Labrosse - SVP, Halozyme Therapeutics, Inc

As of November 16, 2022

What is Nicole Labrosse's Net Worth?

The current estimated net worth of Halozyme Therapeutics, Inc's SVP, Nicole Labrosse, is estimated to be about $710.05K . Nicole Labrosse owns about 4,045 units of Halozyme Therapeutics, Inc common stock. In the last 10 months at Halozyme Therapeutics, Inc, Nicole Labrosse has sold an estimated value of $351.44K worth.

What is Nicole Labrosse's Past Insider Trading?

Nicole Labrosse's largest sale order was 5,000 units , worth over $269.05K on November 16, 2022. In total, Nicole Labrosse has made about 3 transactions over 10 months of their time at Halozyme Therapeutics, Inc. Nicole Labrosse usually trades in February, with the busiest year in 2022.

Nicole LaBrosse

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Nicole Labrosse's' Mailing Address?

  • Mailing address is 11388 Sorrento Valley Road San Diego CA 92121 CA

Halozyme Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Helen I. Torley 2020 $791,440 - $2,500,018 $2,500,001 $712,270 $15,147 $6,518,876
Helen I. Torley 2019 $761,000 - $2,184,130 $2,184,128 $712,296 $15,572 $5,857,126
Helen I. Torley 2018 $725,000 - $2,115,640 $2,115,631 $831,665 $11,733 $5,799,669
Elaine D. Sun 2020 $395,833 $150,000 $1,500,269 $1,000,008 $180,352 $133,399 $3,359,861
Laurie D. Stelzer 2020 $93,225 - - - - $77,996 $171,221
Laurie D. Stelzer 2019 $495,000 $2,500 $750,016 $750,005 $231,660 $16,939 $2,246,120
Laurie D. Stelzer 2018 $470,000 - $575,018 $575,009 $323,489 $9,409 $1,952,925
Masaru Matsuda 2020 $440,000 $50,000 $500,019 $500,008 $203,940 $13,901 $1,707,868
Michael J. LaBarre 2020 $475,000 - $650,009 $650,007 $220,163 $15,018 $2,010,197
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1159036/000115903621000019/halodefproxy2021.htm

What are Halozyme Therapeutics, Inc's Past Insider Trades?

Halozyme Therapeutics, Inc's most recent insider trade came on November 17, 2022 by Helen Torley who sold 30,000 units worth $1.6M . In the last 15 years, insiders at Halozyme Therapeutics, Inc have sold an estimated value of $133.92M and bought an estimated value of $81.73M worth of shares. Insider trading is most common in May and February, with the busiest year in 2007. The most active traders at the company are Helen Torley, PRESIDENT AND CEO,  Gregory Ian Frost, CEO,  and Randal J Kirk .

HALOZYME THERAPEUTICS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1